Probucol
Showing 1 - 25 of 32
Peripheral Artery Disease Trial in Seoul (Cilostazol, Probucol)
Completed
- Peripheral Artery Disease
- Cilostazol, Probucol
-
Seoul, Korea, Republic ofAsan Medical Center
Jul 14, 2022
Healthy Trial in Seoul (probucol)
Completed
- Healthy
- probucol
-
Seoul, Korea, Republic ofSeoul national univeristy
Feb 17, 2022
Healthy Trial in Seoul (Cilostazol, Probucol)
Completed
- Healthy
- Cilostazol
- Probucol
-
Seoul, Korea, Republic ofClinical Trial Center, Seoul National University Hospital
Feb 17, 2022
Stroke, Ischemic, Atherosclerosis, Cerebral Trial in ShenYang (Atorvastatin Calcium, Probucol, PCSK9 inhibitor)
Recruiting
- Stroke, Ischemic
- Atherosclerosis, Cerebral
- Atorvastatin Calcium
- +2 more
-
ShenYang, ChinaGeneral Hospital of ShenYang Military Region
Jan 11, 2022
Hyperlipidemias Trial in Seogu, Seoul, Seongnam-si (HMG-CoA Reductase Inhibitor, Probucol, Cilostazol)
Completed
- Hyperlipidemias
- HMG-CoA Reductase Inhibitor
- +2 more
-
Seogu, Busan, Korea, Republic of
- +4 more
Sep 18, 2019
Coroflex ISAR 2000 Extended Registry (ISAR2000 Extended)
Completed
- Coronary Artery Disease (CAD)
- stenting with the Coroflex ISAR sirolimus-eluting stent
-
Berlin, Germany
- +2 more
Feb 7, 2022
Coronary Artery Disease Trial in Vigo, Madrid (Polymer-free stent, Biodegradable-polymer stent)
Completed
- Coronary Artery Disease
- Polymer-free stent
- Biodegradable-polymer stent
-
Vigo, Pontevedra, Spain
- +2 more
Aug 20, 2019
Diabetes, Type 2 Trial in Jinan (behavioral, drug, other)
Recruiting
- Diabetes Mellitus, Type 2
- Lifestyle therapy
- +3 more
-
Jinan, Shandong, China
- +1 more
Jul 5, 2021
Alagille Syndrome, Atorvastatin, Xanthoma Trial in Shanghai (atorvastatin)
Recruiting
- Alagille Syndrome
- +2 more
-
Shanghai, Shanghai, ChinaChildren's Hospital of Fudan University
Aug 3, 2022
Dementia of the Alzheimer Type, Age-related Cognitive Decline, Mild Cognitive Impairment Due to Alzheimer Trial in Montreal
Completed
- Dementia of the Alzheimer Type
- +2 more
- Probucol
-
Montreal, Quebec, CanadaDouglas Hospital Research Centre
Jan 30, 2018
Diabetic Nephropathy Trial in Korea, Republic of (Probucol 250mg/day, Probucol 500mg/day, Placebo)
Completed
- Diabetic Nephropathy
- Probucol 250mg/day
- +2 more
-
Bucheon, Korea, Republic of
- +15 more
May 1, 2017
Coronary Artery Disease Trial in Barcelona, León (Coroflex® ISAR Drug-eluting stent, Ultimaster® Drug-eluting stent)
Completed
- Coronary Artery Disease
- Coroflex® ISAR Drug-eluting stent
- Ultimaster® Drug-eluting stent
-
Barcelona, Spain
- +2 more
Jan 2, 2019
Coronary Artery Disease (CAD) Trial in Berlin, Kuala Lumpur, Ciudad Real (stenting with the Coroflex ISAR sirolimus-eluting
Completed
- Coronary Artery Disease (CAD)
- stenting with the Coroflex ISAR sirolimus-eluting stent
-
Berlin, Germany
- +2 more
Mar 12, 2018
Type 2 Diabetes, Nephropathy Trial in Guangzhou (Valsartan, Placebo, Probucol)
Unknown status
- Type 2 Diabetes Mellitus
- Nephropathy
- Valsartan
- +2 more
-
Guangzhou, Guangdong, ChinaGuangdong General Hospital
Aug 23, 2016
Safety of Oral Probucol Tablets in Hyperlipidemia -
Completed
- Hyperlipidemia
- (no location specified)
Mar 31, 2016
Brain Ischemia, Intracranial Hemorrhages Trial (cilostazol, Probucol, Aspirin)
Unknown status
- Brain Ischemia
- Intracranial Hemorrhages
- cilostazol
- +5 more
- (no location specified)
Dec 23, 2015
Brain Ischemia, Intracranial Hemorrhages Trial in China, Korea, Republic of, Philippines (Cilostazol, Probucol, Aspirin)
Unknown status
- Brain Ischemia
- Intracranial Hemorrhages
- Cilostazol
- +8 more
-
Hong Kong, Hong Kong, China
- +70 more
Dec 23, 2015
Effects of CHD Prevention on Lipoprotein Subclasses
Completed
- Cardiovascular Diseases
- +2 more
- (no location specified)
Feb 26, 2016
Vascular Basis for the Treatment of Ischemia
Completed
- Cardiovascular Diseases
- +2 more
- (no location specified)
Mar 15, 2016
Chinese Healthy Volunteers Trial in Beijing (Group A: imported Probucol ( Lorelco), Group B: Marketed Probucol ( Chang Tai))
Completed
- Chinese Healthy Volunteers
- Group A: imported Probucol ( Lorelco)
- Group B: Marketed Probucol ( Chang Tai)
-
Beijing, ChinaClinical Pharmacology Research Center Peking Union Medical Colle
Jul 20, 2014
Severe Hypercholesterolemia Trial in Beijing (Atorvastatin, Probucol, Cilostazol)
Unknown status
- Severe Hypercholesterolemia
- Atorvastatin, Probucol, Cilostazol
-
Beijing, ChinaAnzhen hospital
Mar 27, 2014
Glomerulonephritis, IGA Nephropathy Trial in Guangzhou (Valsartan, Probucol, Placebo)
Completed
- Glomerulonephritis
- IGA Nephropathy
- Valsartan
- +2 more
-
Guangzhou, Guangdong, ChinaGuangdong General Hospital
Aug 27, 2013
Healthy Trial in Beijing (Probucol)
Completed
- Healthy
- Probucol
-
Beijing, ChinaClinical Pharmacology Research Center, Peking Union Medical Coll
Jun 4, 2013
Hyperlipidemia Trial in Changsha (Probucol, Placebo)
Completed
- Hyperlipidemia
- Probucol
- Placebo
-
Changsha, Hunan, ChinaThe Sencond Xiangya Hospital of Central South University
Jun 4, 2013
Diabetic Nephropathy Trial in Beijng (Probucol, Probucol and Cilostazol)
Completed
- Diabetic Nephropathy
- Probucol
- Probucol and Cilostazol
-
Beijng, Beijing, ChinaBeijing Universuty First Hospital
May 7, 2013